Work

Clinical Profile Of Single-Agent Modified-Release Oprozomib Tablets In Patients (Pts) With Hematologic Malignancies: Updated Results From a Multicenter, Open-Label, Dose Escalation Phase 1b/2 Study

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3184.3184

Authors: Irene M. Ghobrial, Jonathan L. Kaufman, David S. Siegel, Ravi Vij, Ashraf Badros, Linda Neuman, Hansen Wong, Janet Anderl, Michael Savona

Institutions: Dana-Farber Cancer Institute, Emory University, Winship Cancer Institute, Hackensack University Medical Center, Washington University in St. Louis, University of Maryland, Baltimore, Sarah Cannon

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W302431027

FWCI: 3.417

Cites:

Cited by: 23

Related to: 10